Compare2 funds · 1 pair
Picked · 2YTD
PSCHvsXBIVersus · 5Y · 10.9% held in common2–4measures won
Close to theseFee · YTD
Best of the twoNov 3
  • Lowest cost$ a year on $10kPSCH 0.29%
  • Most incometrailing 12-month yieldXBI 0.35%
  • Best 5 yearsper yearXBI +4.7%
  • Smallest drop · 1Yworst fall in the past yearXBI −14.9%
Measures won2–4XBI wins · of 6 · 5Y
$10,000 · 5Y$12,576XBI · PSCH $9,299
Lowest cost0.29%PSCH · $29 on $10k
Most income0.35%XBI · $35 on $10k
Smallest drop−14.9%XBI · worst fall in 1Y
Held in common10.9%PSCH and XBI

PSCH vs XBI

5Y
PSCH
XBI
Invesco S&P SmallCap Health Care ETF · $178MState Street SPDR S&P Biotech ETF · $10.5B
+16.9%3 years · per year$15,990 · $24,320+34.5%
−1.4%5 years · per year$9,299 · $12,576+4.7%
0.29%Expense ratio$29 · $35 on $10k · lower wins0.35%
0.00%12-mo yield$0 · $35 on $10k0.35%
−15.4%Worst dropSmaller wins−14.9%
19.6%VolatilityLower wins29.1%
2–4XBI wins
$10,000 · 5 yearsOne scale
$10k startXBI $12.6kPSCH $9.3kOct 2021Nov 2026
Shared top holdingsPSCH · XBI
4.4%TGTX1.5%
3.9%ALKS1.4%
4.6%PTGX1.4%
2.6%PTCT1.4%
Held in common10.9%
End-of-day Nov 3, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BXBIState Street SPDR S&P Biotech ETFReadDesk0.35%0.35%+1.9%+27.2%+38.1%+34.5%+4.7%−14.9%$10.5B
2APSCHInvesco S&P SmallCap Health Care ETFReadDesk0.29%0.00%+0.3%+25.9%+31.0%+16.9%−1.4%−15.4%$178M
End-of-day Nov 3, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

PSCH vs XBI

5Y
Invesco S&P SmallCap Health Care
$9,299
SPDR S&P Biotech
$12,576
$10kNov 2021Nov 2026$9,299$12,576$10kNov 2021Nov 2026$9,299$12,576
MeasurePSCHXBI
Fee0.29%0.35%
Cost on $10k a year$29$35
Yield0.00%0.35%
5 years, per year−1.4%+4.7%
3 years, per year+16.9%+34.5%
Worst drop · 1Y−15.4%−14.9%
Volatility · 1Y19.6%29.1%
4–2measures won
XBI first
10.9%
holdings shared
Nov 3, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+32.8%
VIGVanguard
+14.0%
Jan 1Nov 3+32.8%+14.0%
+32.8%Year to date+14.0%
3.0%Yield1.5%
$121BAssets$109B
2–0SCHD wins
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+7.5%
JEPIJ.P. Morgan
+7.0%
Jan 1Nov 3+7.5%+7.0%
+7.5%Year to date+7.0%
12.3%Yield8.0%
$41.8BAssets$46.0B
2–0JEPQ wins
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+11.5%
SPYSPDR
+11.5%
Jan 1Nov 3+11.5%+11.5%
+11.5%Year to date+11.5%
1.0%Yield1.0%
$185BAssets$798B
0–0level
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

Overlap: PSCH, XBI

Today
10.9%most shared, PSCH and XBI
PSCHXBI
PSCH—10.9%
XBI10.9%—
End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$0most kept, XBI
XBI$35 − $35 = $0
PSCH$0 − $29 = −$29
KeptFee
End-of-day Nov 3, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com